• Event Type: Earnings Conference Call for Q2 FY 2026-27 Results
  • Date and Time: Friday, November 6, 2026 at 8:30 AM India Standard Time
  • Purpose: Discussion of quarterly results for Q2 FY 2026-27
  • Regulatory Basis: Disclosure made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Management Participants: Not explicitly mentioned in the disclosure
  • Presentation Availability: No indication of presentation deck, transcript, or recording availability provided
  • UPSI Statement: The document does not contain any specific statement regarding unpublished price sensitive information

Additional Notes Section

  • Financial Data Disclosure: No financial results, figures, or performance data are disclosed in this announcement
  • Attachments: The letter mentions "Encl: As above" referring to the schedule and details of the Earnings Conference Call
  • Contact Information: Investor Relations contact Sameer Arora provided with email investor_relations@ikshealth.com
  • Dial-in Details: Universal access numbers (+91 22 6280 1144/ +91 22 7115 8045) and international toll-free numbers for USA (1 866 746 2133), UK (0 808 101 1573), Singapore (800 101 2045), and Hong Kong (800 964 448) included
  • Registration Links: Participant link and Diamond Pass registration link provided but specific URLs not shown in text

Compliance Details

  • Signing Date: November 2, 2026 at 16:01:26 +05:30
  • Company Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400 708, Thane, Maharashtra, India
  • Company Contacts: Ph: +91 22 3071 1100 | Website: www.ikshealth.com | CIN: L72200MH2006PLC337651